The US Food and Drug Administration (FDA) has approved the first oral agent specifically for postpartum depression, a condition that affects an estimated one in seven mothers in the United States.

When faced with hair loss, many people aren’t sure where to turn for help. They often:

Two newly approved respiratory syncytial virus (RSV) vaccines for adults age 60 years and older may be able to prevent illness in those at risk for severe RSV disease.

24 July 2023 News release Chicago The World Health Organization (WHO) is sharing its latest guidance on sexually transmitted infections (STI) ...

Researchers have observed an association between elevated levels of amyloid-beta and tau in the brain ...

One of the first human studies on how mitochondrial function impacts immune cells to guide future treatments.

Technological breakthroughs in new modalities will be a key driver of growth for the biopharma industry over the next decade.

The FDA today approved a new therapy for early Alzheimer's disease that appears to modestly slow the progression of the disease that affects more than 6.5 million Americans.

WHO has added a fourth test to the list of prequalified tests for human papillomavirus (HPV). Although most HPV infections clear up on their own, some high-risk types could lead to cervical cancer.